Brace Treatment for Idiopathic Scoliosis; PReventing Idiopathic SCOliosis PROgression
Launched by KAROLINSKA INSTITUTET · Mar 17, 2021
Trial Information
Current as of July 24, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how effective brace treatment is for children and teenagers with idiopathic scoliosis, a common condition where the spine curves abnormally. The goal is to find a brace that not only works well in correcting the curve but is also comfortable for young people to wear for long hours each day, as this is crucial for successful treatment. The trial is currently recruiting participants aged 9 to 17 who have a specific degree of spinal curvature and have not previously undergone brace treatment or surgery for scoliosis.
To be eligible for the trial, participants should have a spinal curve between 25 and 40 degrees and be in a stage of growth, which can be determined by certain physical markers. During the trial, participants will wear a brace as part of their treatment plan, and their progress will be closely monitored. This study is important as it aims to improve the comfort and effectiveness of brace treatment, helping to prevent worsening of scoliosis in young patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Cobb 25-40 degrees
- • Skeletally immature, Sanders score of 6 or less and Risser 2 or less.
- • Menarche status maximum one year in females
- • Aged 9-17 years
- • No previous brace treatment or surgery for scoliosis
- • Apex of the primary curve at T7 or caudal
- Exclusion Criteria:
- • Non-idiopathic scoliosis (i.e. neuromuscular, syndromic or congenital scoliosis)
- • Previous spine surgery
About Karolinska Institutet
Karolinska Institutet is a renowned medical university located in Sweden, recognized for its commitment to advancing healthcare through innovative research and education. As a leading sponsor of clinical trials, the institution focuses on translating scientific discoveries into effective treatments and therapies, emphasizing patient-centered approaches. With a strong emphasis on collaboration and interdisciplinary research, Karolinska Institutet plays a pivotal role in addressing global health challenges and improving patient outcomes, leveraging its extensive network of experts and state-of-the-art facilities to drive clinical advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Stockholm, , Sweden
Linköping, , Sweden
Patients applied
Trial Officials
Elias Diarbakerli, PT, PhD
Principal Investigator
Karolinska Institutet
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials